Browsing byAuthorOmari, S
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) |
| 2023-05-17 | Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. | Moles, E; Howard, CB; Huda, P; Karsa, M; McCalmont, H; Kimpton, K; Duly, A; Chen, Y; Huang, Y; Tursky, ML; Ma, D; Bustamante, S; Pickford, R; Connerty, P; Omari, S; Jolly, CJ; Joshi, S; Shen, S; Pimanda, JE; Dolnikov, A; Cheung, LC; Kotecha, RS; Norris, MD; Haber, M; de Bock, CE; Somers, K; Lock, RB; Thurecht, KJ; Kavallaris, M |
| 2021-07-06 | Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia | Van Thillo, Q; De Bie, J; Seneviratne, JA; Demeyer, S; Omari, S; Balachandran, A; Zhai, V; Tam, WL; Sweron, B; Geerdens, E; Gielen, O; Provost, S; Segers, H; Boeckx, N; Marshall, GM; Cheung, BB; Isobe, K; Kato, I; Takita, J; Amos, TG; Deveson, IW; McCalmont, H; Lock, RB; Oxley, EP; Garwood, MM; Dickins, RA; Uyttebroeck, A; Carter, DR; Cools, J; de Bock, CE |
